MedTrace Logo

NT-proBNP as a Tool for the Detection of Acute Pulmonary Artery Embolism (APE)

NCT01633671 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2012-07-06

No results posted yet for this study

Summary

In patients with suspected APE (Acute Pulmonary Embolism) referred to the intensive care unit (ICU)after major surgery, serum NT-proBNP (N-terminal proBNP), Troponin-I and D-dimers were measured according to the standard hospital protocol. To definitively confirm or exclude APE, all patients underwent an angiographic CT-scan of the thorax.

Conditions

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Claus M Muth, MD · Dept. of Anesthesiology, Div. of Emergency medicine, University hospital Ulm, 89075 Ulm, Germany

  • Bernd E Winkler, MD · Dept. of Anesthesiology, University hospital Ulm, 89075 Ulm, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01633671 on ClinicalTrials.gov